Novo Nordisk (NVO) said on Monday that it will cease its partnership with Hims & Hers Health (NYSE:HIMS), ending the direct ...

The FDA had resolved the shortage of Wegovy in April, and telehealth providers were advised to stop selling compounded ...

Ozempic maker Novo Nordisk confirmed Tuesday its popular weight loss drug Wegovy had been approved for sale in China, a key victory for the Danish firm that opens the door to an enormous market ...

Hims & Hers Health stock plunged after Novo Nordisk (NYSE: NVO) cut ties over concerns about its handling of Wegovy ...

Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk NOVO.B1.91%increase; green up pointing triangle to begin selling it in the world’s second ...

of Danish drugmaker Novo Nordisk rose Tuesday after the company announced that its popular weight-loss drug Wegovy has been approved to start being sold in China. Ozempic, another drug with the ...

The good news just keeps rolling in for Wegovy. The drug is now approved in China, a market that Novo Nordisk has long had its eye on. Novo Nordisk already has an established presence in China.

Novo Nordisk‘s hugely popular weight-loss drug Wegovy has been approved in China, it said on Tuesday, the world’s second-largest economy and the country estimated to hold the highest number of ...

Novo Nordisk said Tuesday that its Wegovy weight loss treatment has been approved in China for long-term weight management, opening up the blockbuster drug for sale in the world's second largest ...

SHANGHAI, June 25 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab hugely popular weight-loss drug Wegovy has been approved in China, it said on Tuesday, the world's second-largest economy and ...